Chronic myeloid leukemia, BCR-ABL1-positive, carrying NPM1 mutation – First case series from a single institution
- 1 December 2021
- journal article
- letter
- Published by Elsevier in Leukemia Research
- Vol. 111, 106685
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- NPM1-mutated acute myeloid leukemia: from bench to bedsideBlood, 2020
- The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based settingBlood Advances, 2020
- Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasmsBlood Advances, 2019
- NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapyBlood Advances, 2019
- Chronic Myeloid Leukemia: Beyond BCR-ABL1Current Hematologic Malignancy Reports, 2018
- Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk diseaseBlood, 2018
- Biological and clinical consequences of NPM1 mutations in AMLLeukemia, 2017
- Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutationEuropean Journal of Haematology, 2015
- Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutationsBlood, 2005
- Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal KaryotypeNew England Journal of Medicine, 2005